A carregar...

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension

Endothelin receptor antagonism has emerged as an important therapeutic approach in pulmonary arterial hypertension (PAH). Bench to bedside scientific research has shown that endothelin-1 (ET-1) is overexpressed in several forms of pulmonary vascular disease and may play an important pathogenetic rol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Steiner, M Kathryn, Preston, Ioana R
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605321/
https://ncbi.nlm.nih.gov/pubmed/19183742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!